Bruker Corporation
BRKR
$35.54
$1.745.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.50% | -18.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.50% | -18.19% | |||
| Cost of Revenue | 6.66% | -15.74% | |||
| Gross Profit | -7.83% | -20.56% | |||
| SG&A Expenses | 2.39% | -7.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 20.51% | 128.47% | |||
| Total Operating Expenses | 4.96% | -10.24% | |||
| Operating Income | -58.32% | -57.81% | |||
| Income Before Tax | -95.69% | -53.30% | |||
| Income Tax Expenses | -135.63% | -78.62% | |||
| Earnings from Continuing Operations | -75.00% | 20.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 466.67% | 400.00% | |||
| Net Income | -56.32% | 27.01% | |||
| EBIT | -58.32% | -57.81% | |||
| EBITDA | -28.95% | -44.85% | |||
| EPS Basic | -56.36% | 26.99% | |||
| Normalized Basic EPS | -64.31% | -57.28% | |||
| EPS Diluted | -54.55% | 21.68% | |||
| Normalized Diluted EPS | -64.25% | -57.24% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | -0.13% | -0.07% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 1.26% | -0.20% | |||